A lot of people are surviving cancer because new treatments are so effective. But there's one thing that stands in the way for many people, and that's having the money to pay for the drugs to fight their cancer.
To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
Purdue Pharma, the maker of OxyContin, declared bankruptcy as part of a tentative deal to settle more than 2,000 lawsuits alleging that they and other opioid manufacturers worsened the US opioid epidemic.
The opioid crisis is not just an American problem; it’s a global one.